Optical Brightening Agent AES-X | CAS:24565-13-7

We serve Optical Brightening Agent AES-X CAS:24565-13-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Optical Brightening Agent AES-X

Optical Brightening Agent AES-X
 
Main composition
C.I.No:208
CAS.No:24565-13-7
EINECS:246-320-6
Molecular Mass:840.84
Formula:C36H34N12O6S2Na2
 
Technical index  
Appearance:White or yellowish granule
Ionic Character:Anionic
Moisture Content:≤5.0%
E Value:560±20
Odour:Ammoniacal odour free
 
Performance and Features  
1.AES-X is mainly used for detergent powder whitening. Especially for the fast dissolving detergent powder;
2.Adding AES-X to detergent powder before spray drying, AES-X can homogenize with detergent powder through spray drying.
The recommended dosage is 0.04~0.2% (% W/W Detergent).
 
Packaging and Storage  
Packaging with 25kg bag, 25kg carton, 500kg bag or according to customer's request.
Shelf-life:2 years, store under the room temperature, avoid sunlight and moisture.



Contact us for information like Optical Brightening Agent AES-X chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Optical Brightening Agent AES-X physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Optical Brightening Agent AES-X Use and application,Optical Brightening Agent AES-X technical grade,usp/ep/jp grade.


Related News: Here’s what we can tell you so far:2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one manufacturer But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.Trimethyloxonium Tetrafluoroborate supplier We manufacture APIs and drug manufacturers make medicines from APIs.2-Bromoterephthalic acid vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.